<DOC>
	<DOCNO>NCT02949232</DOCNO>
	<brief_summary>Treatment prednisolone use proof concept investigate possibility immune modulation treatment schizophrenia . It expect daily treatment prednisolone addition antipsychotic treatment reduces psychotic symptom improve cognition , compare placebo . The investigator propose investigate effect administer corticosteroid prednisolone versus placebo addition standard antipsychotic medication patient early stage schizophrenia related disorder , hypothesize decrease overall low-grade cerebral inflammation due prednisolon treatment express decrease overall symptom severity. , Secondly , addition prednisolone hypothesise slow cognitive deterioration recent-onset psychosis patient . Finally , investigator aim determine whether indirect immunological parameter hypothesise low grade inflammation status schizophrenia shift due addition prednisolone .</brief_summary>
	<brief_title>Prednisolone Addition Patients With Recent-onset Psychotic Disorder</brief_title>
	<detailed_description>In current study , investigator aim investigate effect additional treatment prednisolone symptomatic improvement , global functioning , cognition immunological parameter patient early-stage psychotic disorder , apply randomize double-blind placebo-controlled add-on design . A placebo-controlled design choose order differentiate clinical effect prednisolone effect associate experimental treatment , induced expectation participant . Prednisolone placebo provide next existent antipsychotic medication investigator intend replace exist treatment , study Proof Concept trial . It would carry considerable risk patient taper existent antipsychotic medication randomize patient either placebo type therapy efficacy still prove , even short period time . 90 patient schizophrenia , schizoaffective schizophreniform disorder , psychotic disorder NOS ( otherwise specify ) include , age 18-70 year time interval onset psychosis study entry exceed seven year . All 90 in- outpatient randomize 1:1 either prednisolone placebo daily 6 week . Prednisolone initiate 40mg/day 3 day 4 remain day first week 30mg/dag use . During treatment period , patient see weekly interval assess symptom severity , depressive mood suicidal ideation , global functioning side effect .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>1 . A DSMIVR diagnosis : 295.x ( schizophrenia , schizophreniform disorder , schizoaffective disorder ) 298.9 ( psychosis NOS ) 2 . Onset psychosis longer 7 year ago 3 . Minimum total PANSS score 60 4 . Age 18 70 year 5 . Patients treat antipsychotic medication 6 . Written inform consent obtain 7 . Female patient childbearing potential need utilize proper method contraception ( pill , vaginal ring , hormonal patch , intrauterine device , cervical cap , condom , contraceptive injection , diaphragm ) case sexual intercourse study . 1 . Presence contraindication prednisolone report SPC . 2 . Presence diabetes mellitus random ( nonfasting ) glucose level exceed 11 mmol/L screening , severe heart failure , severe osteoporosis systemic fungal infection . 3 . Body Mass Index ( BMI ) &gt; 30.0 4 . Current chronic use systemic glucocorticosteroids ( temporary use permit , stop 1 month start treatment trial ) 5 . Chronic use nonsteroidal antiinflammatory drug , define daily use 2 month . Intermittent use permit , stop least 1 month start treatment trial . 6 . Pregnancy breastfeed . A urine pregnancy test perform screen . 7 . Concurrent use certain type medication : 1. liver enzyme induce medication carbamazepine , riphampicine , primidone , barbiturates phenytoine 2 . HAART medication ( HIV protease inhibitor ( non ) nucleoside reverse transcriptase inhibitor ) , especially efavirenz , ritonavir lopinavir . 3. telaprevir boceprevir treatment Hepatitis C</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>